“…Even though some authors reported an acceptable VO 2max estimation when using step tests in healthy adults (Montoye, ; Ryhming, ; Sloan, ; Kasch et al ., , ; Jette et al ., ; Keren et al ., ; Siconolfi et al ., ; Stevens & Sykes, ; Petrella et al ., ; Chatterjee et al ., , ; D'Alonzo et al ., ; Beutner et al ., ), others reported a systematic under‐ or overestimation of VO 2max (Buckley et al ., ; Vidoni et al ., ). Moreover, these previous studies were limited by small sample sizes (<100 participants) (Sloan, ; Kasch et al ., , ; Jette et al ., ; Keren et al ., ; Stevens & Sykes, ; Chatterjee et al ., ; D'Alonzo et al ., ; Beutner et al ., ), inclusion of non‐representative samples (sportsmen, college students, participants ≥65 years), (Montoye, ; Ryhming, ; Sloan, ; Keren et al ., ; Stevens & Sykes, ; Petrella et al ., ; Chatterjee et al ., , ; D'Alonzo et al ., ), inclusion of subjects with chronic disease (Dal Corso et al ., ; Marcora et al ., ; Kuspinar et al ., ; Vidoni et al ., ) and/or lack of measured VO 2max data (D'Alonzo et al ., ; Kuspinar et al ., ). It follows that the validity of fixed‐rate step tests to estimate VO 2max in a larger group ( n > 100) of healthy subjects free from any chronic disease, and with a wide age range (between 18 and 75 years), still remains to be established.…”